146 related articles for article (PubMed ID: 28028797)
1. GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma.
Almeida LMCA; Silva R; Cavadas B; Lima J; Pereira L; Soares P; Sobrinho-Simões M; Lopes JM; Máximo V
Histol Histopathol; 2017 Oct; 32(10):1029-1040. PubMed ID: 28028797
[TBL] [Abstract][Full Text] [Related]
2. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
[TBL] [Abstract][Full Text] [Related]
3. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
[TBL] [Abstract][Full Text] [Related]
4. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Kim Y; Choi JW; Lee JH; Kim YS
Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
[TBL] [Abstract][Full Text] [Related]
5. Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.
Pértega-Gomes N; Vizcaíno JR; Miranda-Gonçalves V; Pinheiro C; Silva J; Pereira H; Monteiro P; Henrique RM; Reis RM; Lopes C; Baltazar F
BMC Cancer; 2011 Jul; 11():312. PubMed ID: 21787388
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of monocarboxylate transporter expression in oral cavity tumors.
Simões-Sousa S; Granja S; Pinheiro C; Fernandes D; Longatto-Filho A; Laus AC; Alves CD; Suárez-Peñaranda JM; Pérez-Sayáns M; Lopes Carvalho A; Schmitt FC; García-García A; Baltazar F
Cell Cycle; 2016 Jul; 15(14):1865-73. PubMed ID: 27232157
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder.
Choi JW; Kim Y; Lee JH; Kim YS
Urology; 2014 Jul; 84(1):245.e9-15. PubMed ID: 24857275
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression.
Chen H; Wang L; Beretov J; Hao J; Xiao W; Li Y
Clin Exp Metastasis; 2010 Dec; 27(8):557-69. PubMed ID: 20658178
[TBL] [Abstract][Full Text] [Related]
9. Sex Hormones Regulate Rat Hepatic Monocarboxylate Transporter Expression and Membrane Trafficking.
Cao J; Ng M; Felmlee MA
J Pharm Pharm Sci; 2017; 20(1):435-444. PubMed ID: 29249221
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer.
Pinheiro C; Longatto-Filho A; Simões K; Jacob CE; Bresciani CJ; Zilberstein B; Cecconello I; Alves VA; Schmitt F; Baltazar F
Eur J Cancer; 2009 Sep; 45(13):2418-24. PubMed ID: 19628385
[TBL] [Abstract][Full Text] [Related]
11. MCT1 expression is independently related to shorter cancer-specific survival in clear cell renal cell carcinoma.
de Carvalho PA; Bonatelli M; Cordeiro MD; Coelho RF; Reis S; Srougi M; Nahas WC; Pinheiro C; Leite KRM
Carcinogenesis; 2021 Dec; 42(12):1420-1427. PubMed ID: 34668521
[TBL] [Abstract][Full Text] [Related]
12. CD147 expression in advanced cutaneous squamous cell carcinoma.
Sweeny L; Dean NR; Frederick JW; Magnuson JS; Carroll WR; Desmond RA; Rosenthal EL
J Cutan Pathol; 2012 Jun; 39(6):603-9. PubMed ID: 22575025
[TBL] [Abstract][Full Text] [Related]
13. Monocarboxylate transporters 1 and 4 are associated with CD147 in cervical carcinoma.
Pinheiro C; Longatto-Filho A; Pereira SM; Etlinger D; Moreira MA; Jubé LF; Queiroz GS; Schmitt F; Baltazar F
Dis Markers; 2009; 26(3):97-103. PubMed ID: 19597291
[TBL] [Abstract][Full Text] [Related]
14. The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4.
Pinheiro C; Miranda-Gonçalves V; Longatto-Filho A; Vicente AL; Berardinelli GN; Scapulatempo-Neto C; Costa RF; Viana CR; Reis RM; Baltazar F; Vazquez VL
Cell Cycle; 2016 Jun; 15(11):1462-70. PubMed ID: 27105345
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors.
Pinheiro C; Granja S; Longatto-Filho A; Faria AM; Fragoso MC; Lovisolo SM; Lerário AM; Almeida MQ; Baltazar F; Zerbini MC
Oncotarget; 2015 Dec; 6(42):44403-21. PubMed ID: 26587828
[TBL] [Abstract][Full Text] [Related]
16. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.
Martins SF; Amorim R; Viana-Pereira M; Pinheiro C; Costa RF; Silva P; Couto C; Alves S; Fernandes S; Vilaça S; Falcão J; Marques H; Pardal F; Rodrigues M; Preto A; Reis RM; Longatto-Filho A; Baltazar F
BMC Cancer; 2016 Jul; 16():535. PubMed ID: 27460659
[TBL] [Abstract][Full Text] [Related]
17. Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma.
Pinheiro C; Albergaria A; Paredes J; Sousa B; Dufloth R; Vieira D; Schmitt F; Baltazar F
Histopathology; 2010 Jun; 56(7):860-7. PubMed ID: 20636790
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.
Afonso J; Pinto T; Simões-Sousa S; Schmitt F; Longatto-Filho A; Pinheiro C; Marques H; Baltazar F
Cell Oncol (Dordr); 2019 Jun; 42(3):303-318. PubMed ID: 30790227
[TBL] [Abstract][Full Text] [Related]
19. Glucose deprivation increases monocarboxylate transporter 1 (MCT1) expression and MCT1-dependent tumor cell migration.
De Saedeleer CJ; Porporato PE; Copetti T; Pérez-Escuredo J; Payen VL; Brisson L; Feron O; Sonveaux P
Oncogene; 2014 Jul; 33(31):4060-8. PubMed ID: 24166504
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.
Bovenzi CD; Hamilton J; Tassone P; Johnson J; Cognetti DM; Luginbuhl A; Keane WM; Zhan T; Tuluc M; Bar-Ad V; Martinez-Outschoorn U; Curry JM
Biomed Res Int; 2015; 2015():242437. PubMed ID: 26779534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
